Bioavailability Enhancement
Bioavailability Enhancement is a multidisciplinary research and application domain that seeks to increase the proportion of an ingested or administered bioactive substance that is absorbed and becomes available at its intended site of action, by employing genetic, physicochemical, formulation, and delivery strategies to overcome solubility, stability, metabolic, or permeability limitations.
1K
Publications
55.8K
Citations
4.9K
Authors
1.3K
Institutions
Publications per year
2017–2026
486
1K
Jamaluddin Shaikh, D. D. Ankola, Vikas Beniwal et al. · European Journal of Pharmaceutical Sciences · 2009 · 948 citations
1–5 of 1K
4.9K
University of Massachusetts Amherst, United States
11 publications · 1.4K citations
11
h-index
6
h-index
6
h-index
5
h-index
5
h-index
1–5 of 4.9K
1.3K
Shenyang Pharmaceutical University
Shenyang, China
15 h-index
97 publications
4.3K citations

King Abdulaziz University
Jeddah, Saudi Arabia
14 h-index
24 publications
1.4K citations

University of Massachusetts Amherst
Amherst Center, United States
13 h-index
23 publications
2.4K citations

King Saud University
Riyadh, Saudi Arabia
11 h-index
53 publications
2.5K citations

Cairo University
Giza, Egypt
11 h-index
25 publications
947 citations

South China University of Technology
Guangzhou, China
10 h-index
35 publications
2.1K citations
Rutgers, The State University of New Jersey
New Brunswick, United States
10 h-index
34 publications
2.9K citations
Jiangsu University
Zhenjiang, China
10 h-index
52 publications
2.3K citations
1–8 of 1.3K
55 publications · 3.2K citations
32
h-index
36 publications · 1.4K citations
24
h-index
24 publications · 1.6K citations
22
h-index
25 publications · 1.6K citations
21
h-index
25 publications · 1.7K citations
21
h-index
1–5